Publication | Closed Access

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer

VaccinationUrologyMedicineImmunologyTherapeutic VaccineProstate-specific Membrane AntigenImmunotherapeuticsVaccine DesignProstatic DiseaseVaccine Replicon ParticlesPrecision Vaccinology